|
| Time/Date | Code | Headline | Source | Impact |
|---|---|---|---|---|
| 15:24 07-Feb-2013 | GSK | EU submission for BRAF/MEK combination therapy | RNS | +0.82% |
| 12:16 06-Feb-2013 | GSK | GSK applies IAS19R with effect from 1 January 2013 | RNS | +0.33% |
| 12:01 06-Feb-2013 | GSK | Final Results | RNS | +0.33% |
| 14:09 05-Feb-2013 | GSK | Director/PDMR Shareholding | RNS | +0.11% |
| 07:30 05-Feb-2013 | GSK | GSK increases stake in its Indian consumer co. | RNS | +0.11% |
| 16:56 01-Feb-2013 | GSK | Total Voting Rights | RNS | +0.06% |
| 16:21 31-Jan-2013 | GSK | Director/PDMR Shareholding | RNS | +0.70% |
| 15:37 24-Jan-2013 | GSK | Directorate Change | RNS | +2.05% |
| 16:53 21-Jan-2013 | GSK | Director/PDMR Shareholding | RNS | +2.91% |
| 10:00 14-Jan-2013 | GSK | GSK submits albiglutide BLA to the US FDA | RNS | -0.09% |
| 17:11 11-Jan-2013 | GSK | Director/PDMR Shareholding | RNS | -0.55% |
| 17:11 11-Jan-2013 | GSK | Director/PDMR Shareholding | RNS | -0.55% |
| 17:00 10-Jan-2013 | GSK | Director/PDMR Shareholding | RNS | -0.44% |
| 17:00 10-Jan-2013 | GSK | Director/PDMR Shareholding | RNS | -0.44% |
| 16:54 10-Jan-2013 | GSK | Director/PDMR Shareholding | RNS | -0.44% |
| 16:51 10-Jan-2013 | GSK | Director/PDMR Shareholding | RNS | -0.44% |
| 16:47 10-Jan-2013 | GSK | Director/PDMR Shareholding | RNS | -0.44% |
| 17:31 09-Jan-2013 | GSK | Director/PDMR Shareholding | RNS | -0.17% |
| 17:26 09-Jan-2013 | GSK | Director/PDMR Shareholding | RNS | -0.17% |
| 17:20 09-Jan-2013 | GSK | Director/PDMR Shareholding | RNS | -0.17% |
The Exchange accepts no responsibility for the content of the website you are now accessing or for any reliance placed by you or any person on the information contained on it.
By allowing this link the Exchange does not intend in any country, directly or indirectly, to solicit business or offer any securities to any person.
You will be redirected in five seconds.
You are accessing the London Stock Exchange Annual Report Service powered by PrecisionIR.
The Exchange accepts no responsibility for the content of the reports you are now accessing or for any reliance placed by you or any person on the information contained therein.
By allowing this link the Exchange does not intend in any country, directly or indirectly, to solicit business or offer any securities to any person.
You will be redirected in five seconds